RN7SL204P

Across TCGA pan-cancer cohorts, RN7SL204P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RN7SL204P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RN7SL204P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL204P is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

HNSC, LUSC, and STAD are the cancer types where RN7SL204P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL204P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	III,IV	+0.085	.018	8	view →
LUSC	Male	All	−0.070	.016	4	view →
STAD	Male	II,III,IV	+0.306	.013	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RN7SL204P–HNSC

Open the HNSC breakdown →